info@marketresearchfuture.com   📞  +1 (855) 661-4441(US)   📞  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Molecular Diagnostics Companies

Molecular diagnostics companies specialize in developing and providing advanced molecular testing technologies and assays for various medical applications. These technologies play a crucial role in disease diagnosis, personalized medicine, and monitoring treatment responses.


Molecular Diagnostics Key Companies*Disclaimer: List of key companies in no particular orderLatest Molecular diagnostics Companies Update


  • Sep 2023: A final agreement has been reached for the transfer of ownership of Resolution Bioscience to Exact Sciences, a prominent supplier of diagnostic and screening tests for cancer, between Agilent Technologies, Inc., and Exact Sciences Corp. For $695 million, Agilent Technologies purchased Resolution Bioscience Inc., a pioneer in the formation and marketing of precision oncology treatments based on next-generation sequencing (NGS). The acquisition enhanced and expanded Agilent's capabilities in NGS-based cancer diagnostics, giving the business access to front-line technology to better meet the demands of the rapidly expanding precision medicine sector. Resolution Bioscience is a strategic fit for Exact, a leading central laboratory for cancer-related diagnostic testing with substantial expertise and resources. An excellent result of this transaction will be that the skilled Resolution Bioscience team will be able to go on developing diagnostic remedies for their clients and patients thanks to this agreement.




  • Jul 2023: Becton Dickinson's stock reached a record high on Monday and was recently up 6.1% following the medical device manufacturer's approval by the US Food and Drug Administration to take its drug infusion system back to the market late on Friday. Over three years ago, the company recalled a portion of the Alaris pumps because of worries that they would cause medicine to be accidentally, more quickly, or slowly delivered than planned. According to Becton Dickinson, it anticipates shipping the devices and making money in 2024. As of September 30, 2023, it stated that it does not anticipate receiving any significant additional revenue from the Alaris infusion system during the remainder of the fiscal year.


List of Molecular diagnostics Key companies in the market

  • Hoffman La Roche Ltd

  • Hologic Inc.

  • QIAGEN

  • Becton Dickinson and Company

  • Abbott Laboratories

  • Cepheid

  • Siemens

  • Thermo Fisher Scientific

  • Agilent Technologies


Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.